Top Industry Leaders in the Stem Cell Banking Market
Latest Stem Cell Banking Companies Update
-
Sep 2023: Leading fertility and women's health company CooperSurgical recently revealed that Cord Blood Registry® (CBR®) would play a major part in the upcoming Cord Blood Connect meeting, the annual gathering of the Cord Blood Association. The Cord Blood Association is a global nonprofit that accelerates using cord blood and birthing tissues to help patients and enhance science. It also advocates for preserving newborn stem cells in families and the public. For families with a qualified medical need, CBR provides free cord blood and tissue processing through this program, along with five years of storage. The study's findings indicated that the Newborn Possibilities Program's design successfully identifies families more likely to use their cord blood unit for a transplant or experimental infusion. The researchers also pointed out that cord blood banks ought to keep reviewing the requirements for their medical needs program's eligibility in light of pertinent developments regarding the possible value of newborn stem cells, such as modifications to transplant medicine's treatment guidelines and indications, as well as clinical trials and experimental protocols involving related cord blood units.
List of Stem Cell Banking Key companies in the market
-
CBR Systems, Inc. (US)
-
Cryo-Cell International, Inc. (US)
-
Cordlife (Singapore)
-
Cryo-Save AG (Netherlands)
-
Cord Blood Corporation (Hong Kong)
-
Americord Registry LLC (US)
-
Smart Cells International Ltd. (UK)
-
Celgene Corporation (US)
-
BrainStorm Cell Therapeutics (US)
-
Regrow Biosciences Pvt. Ltd. (India).